Mode
Text Size
Log in / Sign up

Diabetes & Endocrinology

905 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
IGF-1R inhibitors significantly improve proptosis and overall response in patients with thyroid eye disease
Diabetes & Endocrinology Meta-analysis
IGF-1R inhibitors significantly improve proptosis and overall response in patients with thyroid eye disease IGF-1R Inhibitors Show Promise for Thyroid Eye Disease Treatment
This meta-analysis of randomized controlled trials evaluated IGF-1R inhibitors (teprotumumab, IBI311, and veligrotug) for thyroid eye diseas…
New analysis shows IGF-1R inhibitors like teprotumumab significantly improve eye protrusion and quality of life for those with thyroid eye d…
Taijiquan and Baduanjin significantly improve depressive symptoms and glycemic control in Type 2 Diabetes
Diabetes & Endocrinology Meta-analysis
Taijiquan and Baduanjin significantly improve depressive symptoms and glycemic control in Type 2 Diabetes Traditional Chinese fitness methods may help manage diabetes and depression
This meta-analysis evaluated the impact of Traditional Chinese fitness methods on patients with Type 2 Diabetes and comorbid depression. The…
Traditional Chinese fitness methods like Taijiquan and Baduanjin may improve mood and blood sugar levels for people with Type 2 diabetes and…
Obesity is associated with significantly worse cognitive performance across six domains in youth
Diabetes & Endocrinology Meta-analysis
Obesity is associated with significantly worse cognitive performance across six domains in youth Obesity Linked to Lower Cognitive Performance in Children and Teens
This meta-analysis of 22 studies indicates that youth with obesity perform significantly worse in inhibition, cognitive flexibility, working…
A review of 22 studies shows that children and adolescents with obesity may perform worse on several key cognitive tasks compared to their p…
Circulating SFRP4 is significantly higher in type 2 diabetes than in healthy controls
Diabetes & Endocrinology Meta-analysis
Circulating SFRP4 is significantly higher in type 2 diabetes than in healthy controls Higher levels of SFRP4 linked to Type 2 Diabetes
This meta-analysis pooled data from 631 individuals with type 2 diabetes and 467 controls to compare circulating SFRP4 levels. SFRP4 was sig…
A new look at blood levels shows that a specific protein, SFRP4, is significantly higher in people with Type 2 Diabetes.
Fatty pancreas disorder is associated with higher odds of fatty liver and diabetes mellitus
Diabetes & Endocrinology Meta-analysis
Fatty pancreas disorder is associated with higher odds of fatty liver and diabetes mellitus Fatty pancreas disorder linked to higher risk of diabetes
This meta-analysis of 6,834 patients found that fatty pancreas disorder (FPD) is associated with a 7.87 odds ratio for fatty liver and a 3.1…
People with a fatty pancreas are much more likely to develop fatty liver disease and diabetes than those without the condition.
Indole-AhR-Treg axis proposed as context-dependent target for restoring tolerance in type 1 diabetes
Diabetes & Endocrinology Sys. Review
Indole-AhR-Treg axis proposed as context-dependent target for restoring tolerance in type 1 diabetes Gut Metabolites May Help Explain Type 1 Diabetes Immune Attack
This narrative review synthesizes mechanistic and translational evidence on microbiome-derived tryptophan indole metabolites (IAA, ICA, IPA)…
Gut bacteria make molecules that may calm the immune attack in type 1 diabetes. A new review explains how this could work, but human proof i…
Low vitamin D linked to higher obesity risk, but detection methods alter findings
Diabetes & Endocrinology Meta-analysis
Low vitamin D linked to higher obesity risk, but detection methods alter findings Link Between Low Vitamin D Levels and Higher Risk of Obesity
This meta-analysis of 74 observational studies (110,838 individuals) found lower serum 25-hydroxyvitamin D concentrations and higher vitamin…
A large review of over 110,000 people shows that those with obesity often have much lower levels of vitamin D in their bodies.
Cortisol excess drives skeletal fragility beyond BMD in endogenous Cushing's syndrome
Diabetes & Endocrinology Sys. Review
Cortisol excess drives skeletal fragility beyond BMD in endogenous Cushing's syndrome Cushing's Syndrome Weakens Bones Even When Scans Look Fine
Narrative review of skeletal fragility in endogenous Cushing's syndrome reports densitometric osteoporosis in approximately 30-50% and fragi…
Up to 76% of people with Cushing's syndrome suffer fractures, often with normal bone density. Standard scans miss the danger.
Anti-inflammatory strategies may stabilize mental functioning and promote autonomic and metabolic homeostasis
Diabetes & Endocrinology Sys. Review
Anti-inflammatory strategies may stabilize mental functioning and promote autonomic and metabolic homeostasis Inflammation and Nerve Imbalance Linked to Anxiety and Metabolic Ills
This narrative review explores the roles of metainflammation, autonomic instability, and anti-inflammatory strategies in anxiety and cardiom…
A new review links chronic inflammation and unstable nerve signals to anxiety, obesity, and diabetes, but it is early, broad thinking, not p…
PMOS proposed as developmental disorder shaped by gene-environment and epigenetic mechanisms
Diabetes & Endocrinology Guideline
PMOS proposed as developmental disorder shaped by gene-environment and epigenetic mechanisms New framework explains how polycystic ovary syndrome develops in women
This guideline-based review proposes a developmental origin framework for polyendocrine metabolic ovarian syndrome (PMOS) and discusses the …
A new framework suggests that polycystic ovary syndrome may begin during development due to how genes and the environment interact.
Efficacy of GLP-1 Receptor Agonists in Managing MASLD and MASH Clinical Outcomes
Diabetes & Endocrinology Meta-analysis
Efficacy of GLP-1 Receptor Agonists in Managing MASLD and MASH Clinical Outcomes GLP-1 Drugs Linked to Less Liver Fat and Weight Loss
GLP-1 receptor agonists demonstrate significant reductions in liver fat, body weight, and transaminases in patients with MASLD or MASH.
A pooled analysis of 795 adults links GLP-1 drugs to less liver fat, lower liver enzymes, and modest weight loss in fatty liver disease.
Sodium glucose co-transporter inhibitors show strongest cognitive improvement in Type 2 Diabetes patients
Diabetes & Endocrinology Meta-analysis
Sodium glucose co-transporter inhibitors show strongest cognitive improvement in Type 2 Diabetes patients New data shows specific diabetes drugs may help brain health
This umbrella review of 213,604 patients with Type 2 Diabetes Mellitus and cognitive impairment found that sodium glucose co-transporter inh…
New research shows that certain diabetes medications and regular exercise may help protect brain function in people with Type 2 Diabetes.